New radiation treatment could spare older women from breast cancer surgery
NCT ID NCT07242118
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a precise, high-dose radiation treatment called SABR as an alternative to surgery for women aged 65 and older with early-stage breast cancer. The goal is to control the cancer while avoiding surgery and maintaining quality of life. Participants will receive five radiation treatments and be monitored for side effects and well-being over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SABR (stereotactic ablative radiotherapy)
What this could lead to
If successful, this could offer older women with breast cancer a non-surgical treatment option that controls the disease while preserving quality of life.
What could go wrong
This is a small, early-phase study with only 18 participants, so results may not apply to all patients. Radiation side effects are possible, and the treatment may not control the cancer long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kansas Medical Center
NOT_YET_RECRUITINGKansas City, Kansas, 66160, United States
-
University of Kansas Medical Center
RECRUITINGKansas City, Kansas, 66160, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••